10x Genomics News

The Analyst Landscape: 4 Takes On 10x Genomics

In the last three months, 4 analysts have published ratings on 10x Genomics (NASDAQ:TXG), offering a diverse range of perspectives from bullish to bearish.The table below offers a condensed view of th

BenzingaApr 18 13:00 ET

10x Genomics Is Maintained at Buy by Deutsche Bank

10x Genomics Is Maintained at Buy by Deutsche Bank

Dow JonesApr 18 08:23 ET

10x Genomics Price Target Cut to $55.00/Share From $60.00 by Deutsche Bank

10x Genomics Price Target Cut to $55.00/Share From $60.00 by Deutsche Bank

Dow JonesApr 18 08:23 ET

Express News | 10X Genomics Inc : Deutsche Bank Cuts Target Price to $55 From $60

Moomoo 24/7Apr 18 02:20 ET

Express News | 10X Genomics Inc : BofA Global Research Cuts Price Objective to $45 From $54

Moomoo 24/7Apr 17 06:25 ET

Express News | 10X Genomics Inc : TD Cowen Cuts Target Price to $57 From $70

Moomoo 24/7Apr 17 06:03 ET

Express News | 10X Genomics Inc : Guggenheim Cuts Target Price to $50 From $60

Moomoo 24/7Apr 16 06:44 ET

10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024

PLEASANTON, Calif., April 10, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report financial results for the first q

PR NewswireApr 10 16:05 ET

10x Genomics Is Maintained at Overweight by Barclays

10x Genomics Is Maintained at Overweight by Barclays

Dow JonesApr 10 15:49 ET

Express News | Barclays Maintains Overweight on 10x Genomics, Lowers Price Target to $45

Moomoo 24/7Apr 10 15:38 ET

10x Genomics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/10/2024 26.48% Barclays $55 → $45 Maintains Overweight 02/16/2024 77.07% Stifel $68 → $63 Maintains Buy

BenzingaApr 10 15:37 ET

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)

TipRanksApr 10 02:51 ET

Top 10 Worst Performing Cathie Wood ARKK Holdings of 2024

Seeking AlphaApr 5 14:32 ET

10x Genomics Insiders Sold US$3.6m Of Shares Suggesting Hesitancy

Over the past year, many 10x Genomics, Inc. (NASDAQ:TXG) insiders sold a significant stake in the company which may have piqued investors' interest. When analyzing insider transactions, it is usuall

Simply Wall StApr 5 09:49 ET

Cathie Wood's Ark Invest Sheds $6.4M Worth Of Coinbase Shares Despite Positive Market Movements, Analyst Upgrade

On Thursday, Cathie Wood-led Ark Invest made a significant move by selling shares of Coinbase Global Inc (NASDAQ:COIN), despite the stock's positive market performance on the same day.The COIN TradeAr

BenzingaApr 4 23:03 ET

Next Generation Sequencing Market Size Is Set to Grow by USD 3409.76 Million From 2023-2027, 10X Genomics Inc., Azenta Inc. & BGI Genomics Co. Ltd., and More to Emerge as Some of the Key Vendors, Technavio

The global next generation sequencing market size is estimated to grow by USD 3409.76 million from 2023 to 2027, according to Technavio. The market...

PR NewswireApr 4 05:21 ET

Research Alert: CFRA Lifts Opinion On Shares Of 10x Genomics, Inc. To Buy From Hold

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Following the recent sell-off in TXG sha

MT NewswiresMar 26 15:05 ET

Express News | 10x Genomics Launches Visium HD Spatial Gene Expression Assay

Moomoo 24/7Mar 26 09:06 ET

10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Visium HD Spatial...

PR NewswireMar 26 09:00 ET

10x Genomics Expands Xenium Menu With Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel

PRNewswireMar 21 16:05 ET